Login

Jungheinrich CEO: From Challenges to Comeback | Lars Brzoska - CEO of Jungheinrich 00:10:00

Share On Facebook Share On Twitter

Lars Brzoska is Chairman-Mgmt Board/CEO at Jungheinrich AG.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Inside Look: Privacy and Cybersecurity Law with Alex Rutherford | Miguel A. Zaldivar, Jr. - Chief Executive Officer of Hogan Lovells
00:10:00
China's Economic Recovery and Its Impact on Metals Price
00:10:00
Strong Financial Performance and Strategic Vision: Santander's 2023 Achievements | Hector Grisi , CEO , Banco Santander.
00:10:00
Getting Reeled In: Meet Ryan Simpson at Syverson Strege | Ryan Simpson, Associate Financial Planner of Syverson Strege
00:10:00
From Intern to Owner: Craig Novorr's Journey to Leading Paragon Capital | Howard Jacobson - Founder of Paragon Capital Management, Ltd.
00:10:00
Everest Wealth Management: Secure Your Retirement with Guaranteed Growth
00:10:00
Neil Abramson on Mastering Collective Bargaining | Neil H. Abramson - Partner, Proskauer Rose LLP
00:10:00
Evolving Story: Investing in Africa's Renewable Energy Future | Akinwole Omoboriowo ll, CEO, Geregu Power PLC.
00:10:00
Renegade ETF Issuer Matt Tuttle on Launching Bold, Buzz-Worthy Funds
00:10:00
Retiring Early Is Overrated: Focus on Financial Independence | Lori Bodenhamer - Financial Planner of Abundo Wealth
00:10:00
Advancing AI for Good: Microsoft and Waterloo AI Institute Unite for Innovation
00:10:00
Evli Fund Management Company Ltd. provides insights into the market outlook for infrastructure investments.

© 2026 Nehu